| Literature DB >> 30253751 |
Leticia P Sanglard1,2, Moysés Nascimento2,3, Philipe Moriel4, Jeffrey Sommer2, Melissa Ashwell2, Matthew H Poore2, Márcio de S Duarte5,6, Nick V L Serão7,8.
Abstract
BACKGROUND: Maternal nutrition has been highlighted as one of the main factors affecting intra-uterine environment. The increase in nutritional requirements by beef cows during late gestation can cause nutritional deficiency in the fetus and impact the fetal regulation of genes associated with myogenesis and immune response.Entities:
Keywords: Fetal development; Fetal programming; Gene expression; RNA-seq
Mesh:
Year: 2018 PMID: 30253751 PMCID: PMC6156876 DOI: 10.1186/s12864-018-5089-8
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Venn Diagram with the number of differentially expressed genes (DEG; q-value < 0.05) for the effects of diet, sex, and diet-by-sex for muscle (a), and diet, sex and diet-by-time for blood (b)
Fig. 2Volcano plots for the effect of sex (a) and diet (b) in the muscle tissue, and for the effect of diet (c) in the blood tissue. The Y-axis shows the –log10 q-values for the effects of sex (a) or diet (b and c), whereas the X-axis represents the fold change (FC), with FC equal 1 representing equal expression between the two compared groups. In A, FC values to the left and right represent the up-regulation of DEG in male and female calves, respectively. In B and C, FC values to the left and right represent up-regulation of DEG in the control and restricted diets, respectively. Genes with significant (q-value < 0.05) effect of diet are highlighted in red. Extreme values of FC (< or > 5) and q-value (< 1.0E-06) were removed from the plot
Enrichment analysis showing 20 most overrepresented1 Biological Process for differentially expressed genes2 for the effects of diet and sex in the muscle tissue
| Biological Process | # genes | FE | |
|---|---|---|---|
|
| |||
| Positive regulation of actin cytoskeleton reorganization (GO:2000251) | 2 | 21.68 | 4.88E-03 |
| Peptidyl-proline hydroxylation (GO:0019511) | 2 | 21.68 | 4.88E-03 |
| Positive regulation of blood vessel endothelial cell migration (GO:0043536) | 3 | 13.21 | 1.90E-03 |
| Negative regulation of myeloid cell differentiation (GO:0045638) | 4 | 9.56 | 1.02E-03 |
| Membrane depolarization (GO:0051899) | 3 | 9.4 | 4.70E-03 |
| Regulation of protein targeting (GO:1903533) | 4 | 6.33 | 4.26E-03 |
| Negative regulation of hemopoiesis (GO:1903707) | 4 | 5.75 | 5.90E-03 |
| Regulation of cell morphogenesis involved in differentiation (GO:0010769) | 6 | 4.55 | 2.44E-03 |
| Regulation of mitochondrion organization (GO:0010821) | 5 | 4.49 | 5.87E-03 |
| Regulation of neuron projection development (GO:0010975) | 8 | 4.27 | 7.09E-04 |
| Regulation of intracellular transport (GO:0032386) | 7 | 3.55 | 4.16E-03 |
| Regulation of cell morphogenesis (GO:0022604) | 8 | 3.33 | 3.28E-03 |
| Regulation of neuron differentiation (GO:0045664) | 9 | 3.32 | 1.86E-03 |
| Positive regulation of transport (GO:0051050) | 14 | 2.92 | 3.81E-04 |
| Regulation of plasma membrane bounded cell projection organization (GO:0120035) | 8 | 2.86 | 7.79E-03 |
| Regulation of neurogenesis (GO:0050767) | 9 | 2.68 | 7.28E-03 |
| Regulation of nervous system development (GO:0051960) | 10 | 2.55 | 6.61E-03 |
| Regulation of transport (GO:0051049) | 20 | 2.08 | 2.13E-03 |
| Cell surface receptor signaling pathway (GO:0007166) | 20 | 1.87 | 6.52E-03 |
| Regulation of localization (GO:0032879) | 25 | 1.74 | 7.58E-03 |
|
| |||
| Histone H3-K27 demethylation (GO:0071557) | 2 | 55.66 | 1.04E-03 |
| Kinetochore assembly (GO:0051382) | 3 | 52.18 | 5.64E-05 |
| Positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2 | 39.76 | 1.76E-03 |
| Kinetochore organization (GO:0051383) | 3 | 34.79 | 1.52E-04 |
| Positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3 | 34.79 | 1.52E-04 |
| Regulation of skeletal muscle contraction (GO:0014819) | 2 | 34.79 | 2.19E-03 |
| Positive regulation of glycoprotein metabolic process (GO:1903020) | 3 | 29.82 | 2.25E-04 |
| Centromere complex assembly (GO:0034508) | 3 | 21.97 | 4.97E-04 |
| Establishment of melanosome localization (GO:0032401) | 3 | 20.87 | 5.68E-04 |
| Establishment of pigment granule localization (GO:0051905) | 3 | 19.88 | 6.46E-04 |
| Melanosome localization (GO:0032400) | 3 | 19.88 | 6.46E-04 |
| Pigment granule localization (GO:0051875) | 3 | 18.98 | 7.30E-04 |
| ATP hydrolysis coupled transmembrane transport (GO:0090662) | 3 | 16.06 | 1.14E-03 |
| ATP hydrolysis coupled proton transport (GO:0015991) | 3 | 16.06 | 1.14E-03 |
| Energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3 | 14.91 | 1.38E-03 |
| Regulation of glucose metabolic process (GO:0010906) | 5 | 9.53 | 2.41E-04 |
| Regulation of cellular carbohydrate metabolic process (GO:0010675) | 5 | 7.65 | 6.29E-04 |
| Regulation of carbohydrate metabolic process (GO:0006109) | 5 | 6.5 | 1.26E-03 |
| Chromosome organization (GO:0051276) | 17 | 2.59 | 3.56E-04 |
| Cellular macromolecular complex assembly (GO:0034622) | 14 | 2.57 | 1.32E-03 |
1P-value < 0.05;
2q-value < 0.05;
FE = fold enrichment
The 10 most significant up- and down-regulated differentially expressed genes1 in the muscle tissue for the effects of Diet2 and Sex3
| Gene symbol | Gene name | Biological function | FC [CI] | |
|---|---|---|---|---|
|
| ||||
| SPATA1 | Spermatogenesis associated 1 | Involved in male fertility [ | 2.28 [1.54, 3.39] | 3.91E-03 |
| SYT3 | Synaptotagmin 3 | Involved in glucose metabolism [ | 1.89 [1.39, 2.57] | 3.75E-03 |
| FZD5 | Frizzled class receptor 5 | Wnt/Wingless (Wg) signals [ | 1.84 [1.35, 2.5] | 8.00E-03 |
| AQP4 | Aquaporin 4 | Water channels [ | 1.62 [1.28, 2.06] | 3.97E-03 |
| CHN1 | Chimerin 1 | GTPase-activating protein [ | 1.48 [1.22, 1.82] | 5.59E-03 |
| ETNPPL | Ethanolamine-phosphate phospholyase | Associated to fatty acid and lipid metabolic process [ | 1.33 [1.19, 1.48] | 1.56E-04 |
| SMIM11A | Small integral membrane protein 11A | 1.26 [1.14, 1.39] | 8.36E-04 | |
| ETFRF1 | Electron transfer flavoprotein regulatory factor 1 | Involved in fatty acid oxidation [ | 1.24 [1.12, 1.37] | 3.97E-03 |
| TMCC2 | Transmembrane and coiled-coil domain family 2 | Play a role in neurodegeneration [ | 1.21 [1.1, 1.31] | 2.91E-03 |
| TRAPPC6B | Trafficking protein particle complex 6B | Vesicle transport [ | 1.1 [1.06, 1.15] | 5.42E-04 |
| ATP6V0D1 | ATPase H+ transporting V0 subunit d1 | Involved in oxidative phosphorylation [ | 0.89 [0.85, 0.93] | 1.67E-04 |
| RTF2 | Replication termination factor 2 | Riboflavin transporters [ | 0.89 [0.84, 0.94] | 1.62E-03 |
| MLX | MAX dimerization protein | Control cell cycle [ | 0.82 [0.77, 0.88] | 2.44E-05 |
| GPC4 | Glypican 4 | Involved in cell proliferation [ | 0.81 [0.74, 0.89] | 1.41E-03 |
| TSPAN7 | Tetraspanin 7 | Maturation of glutamatergic synapses [ | 0.81 [0.74, 0.88] | 1.31E-04 |
| SLCO3A1 | Solute carrier organic anion transporter family member 3A1 | Thyroid hormone membrane transporter involved in satellite cell differentiation [ | 0.77 [0.71, 0.84] | 4.58E-07 |
| RASD2 | RASD family member 2 | Involved in cellular movement and cell cycle [ | 0.76 [0.68, 0.86] | 2.25E-03 |
| LAT | Inker for activation of T cells | T cell activation [ | 0.63 [0.53, 0.75] | 1.91E-05 |
| SLC2A1 | Solute carrier family 2 member 1 | Glucose transporter [ | 0.62 [0.51, 0.75] | 1.67E-04 |
| RASL10B | RAS like family 10 member B | Potential tumor suppression [ | 0.51 [0.38, 0.68] | 6.60E-04 |
|
| ||||
| FAAP24 | Fanconi anemia core complex associated protein 24 | DNA damage response [ | 2.14 [1.6, 2.87] | 1.67E-05 |
| TXLNG | Taxilin gamma | 1.93 [1.59, 2.35] | 8.48E-10 | |
| KDM6A | Lysine demethylase 6A | Demethylase [ | 1.67 [1.51, 1.85] | < 1.00E-13 |
| ZRSR2 | Zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2 | 1.61 [1.39, 1.88] | 4.27E-08 | |
| EIF2S3 | Eukaryotic translation initiation factor 2 subunit gamma | Play a role in pituitary development and insulin secretion [ | 1.48 [1.38, 1.6] | < 1.00E-13 |
| SRD5A3 | Steroid 5 alpha-reductase 3 | Produces steroid hormones [ | 1.38 [1.24, 1.53] | 6.49E-08 |
| TMCC2 | Transmembrane and coiled-coil domain family 2 | 1.28 [1.16, 1.4] | 1.30E-05 | |
| SYAP1 | Synapse associated protein 1 | 1.27 [1.21, 1.34] | < 1.00E-13 | |
| USP9X | Ubiquitin specific peptidase 9, X-linked | TGF-β signaling [ | 1.25 [1.14, 1.37] | 1.15E-04 |
| ICMT | Isoprenylcysteine carboxyl methyltransferase | Methyltransferase [ | 1.24 [1.13, 1.35] | 1.26E-04 |
| ARID1B | AT-rich interaction domain 1B | Regulation of cell cycle [ | 0.87 [0.82, 0.93] | 2.77E-04 |
| ZBED1 | Zinc finger BED-type containing 1 | Associated with cell proliferation [ | 0.75 [0.66, 0.85] | 1.22E-03 |
| ADAM1B | A disintegrin and metallopeptidase domain 1b | Involved in male fertilization [ | 0.54 [0.41, 0.69] | 1.15E-04 |
| ANOS1 | Anosmin 1 | Cell adhesion [ | 0.53 [0.4, 0.69] | 2.20E-04 |
| GCGR | Glucagon receptor | Glucagon receptor [ | 0.44 [0.3, 0.63] | 6.00E-04 |
| ACTL8 | Actin like 8 | 0.4 [0.27, 0.59] | 2.45E-04 | |
| CD3G | CD3g molecule | T-cell receptor [ | 0.28 [0.17, 0.46] | 8.08E-05 |
| RIMS1 | Regulating synaptic membrane exocytosis 1 | Maintenance of normal synaptic function [ | 0.14 [0.1, 0.19] | < 1.00E-13 |
| LOC107131205 | Lysine-specific demethylase 6A-like | Antioxidant [ | 0.07 [0.06, 0.08] | < 1.00E-13 |
| LOC107131189 | Eukaryotic translation initiation factor 2 subunit 3, Y-linked-like | 0.01 [0.01, 0.01] | < 1.00E-13 | |
1q-value < 0.05;
2Up- and down-regulated in the restricted group compared with the control are represented by values bigger and smaller than 1, respectively;
3Up- and down-regulated in females compared with males are represented by values bigger or smaller than 1, respectively;
Biological Function, based on cited reference;
FC = Fold change;
CI = 95% Confidence Interval
Enrichment analysis showing 20 most overrepresented1 Biological Process for differentially expressed genes2 for diet and biologically relevant contrasts in the blood tissue
| Biological Process | # genes | FE | |
|---|---|---|---|
|
| |||
| Regulation of carbohydrate metabolic process (GO:0006109) | 3 | 6.54 | 1.37E-02 |
| Translation (GO:0006412) | 22 | 4.3 | 3.42E-08 |
| Glycogen metabolic process (GO:0005977) | 3 | 4.03 | 4.38E-02 |
| Transcription initiation from RNA polymerase II promoter (GO:0006367) | 4 | 3.81 | 2.47E-02 |
| rRNA metabolic process (GO:0016072) | 10 | 3.77 | 5.20E-04 |
| Protein targeting (GO:0006605) | 8 | 2.3 | 2.73E-02 |
| Cellular component biogenesis (GO:0044085) | 36 | 2.08 | 6.01E-05 |
| Protein localization (GO:0008104) | 18 | 1.72 | 2.71E-02 |
| Organelle organization (GO:0006996) | 39 | 1.51 | 1.36E-02 |
| Biosynthetic process (GO:0009058) | 55 | 1.49 | 4.07E-03 |
| Cellular component organization or biogenesis (GO:0071840) | 65 | 1.48 | 1.68E-03 |
| Cellular component organization (GO:0016043) | 54 | 1.32 | 3.77E-02 |
| Primary metabolic process (GO:0044238) | 119 | 1.19 | 3.26E-02 |
|
| |||
| Translation (GO:0006412) | 101 | 5.84 | 6.58E-42 |
| Peptide biosynthetic process (GO:0043043) | 101 | 5.64 | 8.81E-41 |
| Amide biosynthetic process (GO:0043604) | 103 | 5.09 | 3.67E-38 |
| Peptide metabolic process (GO:0006518) | 103 | 4.8 | 3.40E-36 |
| Cellular amide metabolic process (GO:0043603) | 106 | 4.08 | 7.70E-32 |
| Ribosome biogenesis (GO:0042254) | 37 | 3.65 | 1.55E-10 |
| Organonitrogen compound biosynthetic process (GO:1901566) | 125 | 2.68 | 4.22E-22 |
| Cellular macromolecule biosynthetic process (GO:0034645) | 181 | 2.21 | 4.73E-23 |
| Macromolecule biosynthetic process (GO:0009059) | 181 | 2.17 | 1.99E-22 |
| Cellular nitrogen compound biosynthetic process (GO:0044271) | 165 | 2.11 | 4.11E-19 |
| Gene expression (GO:0010467) | 168 | 1.85 | 3.42E-14 |
| Cellular protein metabolic process (GO:0044267) | 213 | 1.84 | 3.63E-18 |
| Organic substance biosynthetic process (GO:1901576) | 203 | 1.8 | 2.37E-16 |
| Cellular biosynthetic process (GO:0044249) | 198 | 1.8 | 9.94E-16 |
| Biosynthetic process (GO:0009058) | 204 | 1.76 | 1.74E-15 |
| Organelle organization (GO:0006996) | 178 | 1.74 | 6.55E-13 |
| Cellular nitrogen compound metabolic process (GO:0034641) | 232 | 1.7 | 3.41E-16 |
| Protein metabolic process (GO:0019538) | 232 | 1.64 | 1.84E-14 |
| Cellular macromolecule metabolic process (GO:0044260) | 293 | 1.62 | 1.85E-18 |
| Cellular component organization or biogenesis (GO:0071840) | 252 | 1.52 | 2.74E-12 |
| Macromolecule metabolic process (GO:0043170) | 320 | 1.42 | 2.33E-12 |
|
| |||
| Myeloid leukocyte activation (GO:0002274) | 8 | 5.47 | 1.93E-04 |
| Transition metal ion transport (GO:0000041) | 9 | 5.07 | 1.32E-04 |
| Positive regulation of response to external stimulus (GO:0032103) | 14 | 3.22 | 2.06E-04 |
| Positive regulation of GTPase activity (GO:0043547) | 22 | 3.18 | 4.20E-06 |
| Regulation of GTPase activity (GO:0043087) | 23 | 2.87 | 1.27E-05 |
| Positive regulation of hydrolase activity (GO:0051345) | 28 | 2.4 | 3.93E-05 |
| Regulation of response to external stimulus (GO:0032101) | 26 | 2.35 | 9.76E-05 |
| Cellular homeostasis (GO:0019725) | 28 | 2.24 | 1.36E-04 |
| Immune system process (GO:0002376) | 58 | 1.93 | 2.65E-06 |
| Regulation of hydrolase activity (GO:0051336) | 40 | 1.92 | 1.71E-04 |
| Positive regulation of response to stimulus (GO:0048584) | 56 | 1.78 | 3.82E-05 |
| Cellular response to organic substance (GO:0071310) | 55 | 1.77 | 5.19E-05 |
| Cellular response to chemical stimulus (GO:0070887) | 67 | 1.75 | 1.25E-05 |
| Localization (GO:0051179) | 141 | 1.61 | 3.46E-09 |
| Establishment of localization (GO:0051234) | 110 | 1.6 | 6.83E-07 |
| Transport (GO:0006810) | 104 | 1.57 | 3.50E-06 |
| Regulation of response to stimulus (GO:0048583) | 97 | 1.54 | 2.14E-05 |
| Cell differentiation (GO:0030154) | 84 | 1.53 | 8.59E-05 |
| Regulation of signal transduction (GO:0009966) | 77 | 1.53 | 2.22E-04 |
| Regulation of signaling (GO:0023051) | 83 | 1.5 | 2.22E-04 |
| Developmental process (GO:0032502) | 118 | 1.39 | 1.65E-04 |
1P-value < 0.05;
2q-value < 0.05;
FE = fold enrichment
10 most differentially Expressed Genes1 in the blood for biologically relevant contrasts
| Gene symbol | Gene name | Biological function | |
|---|---|---|---|
|
| |||
| | Upstream transcription factor family member 3 | Regulates Major Histocompatibility Complex [ | 1.13E-04 |
| | StAR related lipid transfer domain containing 6 | Structure and lipid transport mechanism [ | 3.10E-04 |
| | Polyhomeotic homolog 3 | 3.17E-04 | |
| | Breast cancer metastasis-suppressor 1 like | Metastasis suppression [ | 4.87E-04 |
| | MPV17L mitochondrial inner membrane protein like | Up- or down-regulation of the genes of antioxidant enzymes [ | 4.92E-04 |
| | Neurobeachin like 1 | Vesicle trafficking, membrane dynamics and receptor signaling [ | 7.31E-04 |
| | Chromosome 5 open reading frame, human C12orf4 | 7.59E-04 | |
| | INO80 complex subunit D | DNA damage responses [ | 8.00E-04 |
| | Tigger transposable element derived 3 | 8.94E-04 | |
| | Killer cell lectin like receptor F1 | Stimulates natural killer (NK) cells cytoxicity and cytokine release [ | 9.05E-04 |
|
| |||
| | Antimicrobial peptide NK-lysin-like | Antimicrobial activity [ | 6.62E-04 |
| | G protein-coupled receptor 161 | Involved in neural tube development [ | 2.13E-03 |
| | Killer cell lectin like receptor F1 | Stimulates NK cells cytoxicity and cytokine release [ | 2.20E-03 |
| | Pro-melanin concentrating hormone | Feed intake control [ | 2.81E-03 |
| | Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma | Control cell proliferation [ | 3.15E-03 |
| | Keratin 24 | 3.64E-03 | |
| | Proline rich transmembrane protein 3 | Protein binding [ | 3.74E-03 |
| | Glutamine rich 2 | Cupper regulation [ | 4.18E-03 |
| | Histone cluster 2 H2A family member B | Play a central role in transcription regulation, DNA repair and DNA replication [ | 4.22E-03 |
| | 2′-5′-oligoadenylate synthetase like | Response to viral infections [ | 4.73E-03 |
1P-value < 0.05 for significant (q-value < 0.05) effects of diet-time interaction;
Biological Function, based on cited reference
Fig. 3The 10 most differentially expressed genes (q-value < 0.05) showing interaction between the effects of diet and weaning in the blood tissue. Bars represent the fold change (FC) for the effect (P-value < 0.05) of diet before (blue) and after (red) weaning, with error bars representing the 95% confidence interval. Fold change values equal to 1 represent same expression between the diets (control and restricted). Fold change values on the top and bottom halves represent up-regulated DEG in the restricted and control groups, respectively. The name and function of these genes are summarized on Table 4
Fig. 4The 10 most differentially expressed genes (q-value < 0.05) showing interaction between the effects of diet and vaccination in the blood tissue. Bars represent the fold change (FC) for the effect (P-value < 0.05) of diet before (blue) and after (red) vaccination, with error bars representing the 95% confidence interval. Fold change values equal to 1 represent same expression between the diets (control and restricted). Fold change values on the top and bottom halves represent up-regulated DEG in the restricted and control groups, respectively. The name and function of these genes are summarized on Table 4
Fig. 5Partial correlation networks for all (a) and the 20 (b) most differentially expressed genes (DEG; q-value < 0.05) for the effect of diet in muscle. Brown and Beige nodes represent down- and up-regulated DEG in the restricted, respectively. Red and green lines represent negative and positive correlation (correlation > |0.8|), respectively
Fig. 6Partial correlation networks for all (a) and the 10 most differentially expressed genes (DEG; q-value < 0.05) for the effect of diet in muscle associated with the 10 most DEG in blood tissue (b). Brown and Beige nodes represent overexpressed DEG in the blood and muscle, respectively. Red and green lines represent negative and positive correlation (correlation > |0.8|), respectively